Narcolepsy - New Potential Treatment

The overall aim of the study is to investigate the effect of a new, non-pharmacological method that may alleviate the symptoms of narcolepsy and thereby lead to a reduction in the use of medications with potentially serious side effects in patients with this disease.

Inclusion Criteria:

• Signed informed consent
• Diagnosed with narcolepsy (diagnose code G47.4)
• 16 - 60 years of age
• MSLT has shown hypersomnia (sleeping latency < 8 min) & 1 episode REM
• HLA-type associated with increased occurrence of narcolepsy

Exclusion Criteria:

• Reduced cognitive function
• Other relevant organ disease (that could affect the study results or put the patient at risk)
• Ongoing bacterial infection in the nose
• Comorbidity that can increase the risk of bleeding
• Has received treatment with an implantable stimulator or other implantable product in the head and / or in the neck
• Known pronounced septal deviation
• Known allergy to polyvinylchloride or medicinal liquid paraffin
• Women not using adequate contraceptives
• Participated in a clinical investigational drug trial within the previous 30 days